Related Experiment Video

Updated: May 4, 2026

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
05:36

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

8.5K

VPA inhibits renal cancer cell migration by targeting HDAC2 and down-regulating HIF-1α

Feng-qiang Yang1, Min Liu, Feng-ping Yang

  • 1Department of Urology, Shanghai Tenth People's Hospital, Tongji University, No 301, Yanchang Mid-Road, Shanghai, 200072, China.

Molecular Biology Reports
|January 7, 2014
PubMed

Insights

Valproic acid (VPA) inhibits human renal cancer cell migration by reducing HIF-1α expression, a process linked to HDAC2. This suggests HDAC2 inhibition could be a therapeutic strategy for kidney cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cell migration is critical in renal cancer mortality, with unclear molecular drivers.
  • Valproic acid (VPA), a histone deacetylase inhibitor, exhibits anticancer properties.
  • Understanding VPA's mechanism in renal cancer is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the effects of VPA on human renal cancer cell migration.
  • To elucidate the molecular mechanisms underlying VPA's impact on renal cancer cells.
  • To explore the role of HDAC2 and HIF-1α in VPA-mediated inhibition of cell migration.

Main Methods:

  • Utilized human renal cancer ACHN cells.
  • Administered Valproic Acid (VPA) and assessed cell migration and proliferation.
  • Performed gene knockdown and overexpression of HIF-1α and HDAC2.
  • Analyzed changes in HIF-1α expression levels.

Main Results:

  • VPA significantly inhibited human renal cancer cell migration, but not proliferation.
  • VPA treatment led to a significant decrease in HIF-1α expression.
  • Knockdown of HIF-1α mimicked VPA's inhibitory effect on migration; its overexpression rescued VPA's effect.
  • Knockdown of HDAC2 replicated VPA's impact on HIF-1α and cell migration.

Conclusions:

  • VPA inhibits renal cancer cell migration via suppression of HIF-1α.
  • HDAC2 plays a key role in VPA's mechanism of action on HIF-1α and cell migration.
  • Targeting HDAC2 with small molecules presents a potential therapeutic avenue for human renal cancer.

More Related Videos

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment10:59

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment

Published on: November 23, 2017

9.4K
Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy09:17

Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy

Published on: September 16, 2019

6.3K

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K